Skip to main content
JW LIFESCIENCE CORPORATION logo

JW LIFESCIENCE CORPORATION — Investor Relations & Filings

Ticker · 234080 ISIN · KR7234080000 KO Manufacturing
Filings indexed 191 across all filing types
Latest filing 2020-05-07 Earnings Release
Country KR South Korea
Listing KO 234080

About JW LIFESCIENCE CORPORATION

https://www.jw-lifescience.co.kr/lifesc…

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a short, preliminary announcement of quarterly financial results (20.1Q) for JW Life Science. It provides key highlights such as revenue, operating profit, and net income in a table format. Since it is an initial announcement of financial results rather than a full report, it falls under the Earnings Release category. Q1 2020
2020-05-07 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in JW Life Science (JW생명과학). This type of filing is a standard regulatory requirement for institutional investors when they cross specific ownership thresholds (typically 5%). In the provided classification schema, this corresponds to a 'Major Shareholding Notification'.
2020-04-03 Korean
타인에대한채무보증결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory announcement regarding a 'Decision on Debt Guarantee for Others' (타인에 대한 채무보증결정) issued by JW Life Science. It details the financial terms, the relationship between the entities, and the board's approval. Since this is a specific regulatory disclosure regarding corporate financing/guarantees that does not fit into the other specific categories like M&A or Share Issues, it is classified as a Regulatory Filing (RNS).
2020-04-01 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for JW Life Science, covering the fiscal year 2019 (Jan 1, 2019 to Dec 31, 2019). It contains comprehensive sections including company overview, business description, financial statements, management discussion and analysis, and governance information. This is a standard annual regulatory filing in South Korea, equivalent to a 10-K in the US market. FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and director/auditor appointments. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-03-27 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report of Change in Shareholding by Major Shareholders and Related Parties) filed with the Korean regulatory authority. It details specific share transactions (purchases) by individuals related to the company, including names, dates, and changes in share counts. This falls under the category of Director's Dealing (DIRS) as it reports insider/major shareholder transactions.
2020-03-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.